Is there a menopausal metabolic syndrome?

References

• Stampfer M., Colditz G., Willett W. Menopause and heart disease: a review. Ann. NY Acad. Sri. 1990; 592: 193–203
   PubMed Web of Science ®Google Scholar
• Wuest J., Dry T., Edwards J. The degree of coronary atherosclerosis in bilaterally oophorectomised women. Circulation 1953; 7: 801–9
   Google Scholar
• Despres J. P., Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr. Opin. Lipidol. 1994; 5: 274–89
   PubMedGoogle Scholar
• Castelli W., Garrison R., Wilson P., Abbott R., Kalousdian S., Kannel W. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. J. Am. Med. Assoc 1986; 256: 2835–8
   PubMed Web of Science ®Google Scholar
• Bass K., Newschaffer C., Klag M., Bush T. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch. Intern. Med. 1993; 153: 2209–16
   PubMed Web of Science ®Google Scholar
• Drexel H., Amann F., Beran J., Rentsch K., Candinas R., Muntwyler J., Luethy A., Gasser T., Follath F. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994; 90: 2230–5
   PubMedGoogle Scholar
• Miller N. Associations of high-density lipoprotein subclasses and apolipoproteins with ischaemic heart disease and coronary atherosclerosis. Am. Heart J. 1987; 113: 589–97
   PubMed Web of Science ®Google Scholar
• Godsland I. F., Crook D., Walton C., Wynn V., Oliver M. F. Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. Arteriosc. Thromb. 1992; 12: 1030–5
   PubMed Web of Science ®Google Scholar
• Steinberg D. Lipoproteins and the pathogenesis of atherosclerosis. Circulation 1987; 76: 508–14
   PubMed Web of Science ®Google Scholar
• Sack M. N., Rader D. J., Cannon R. O., III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenstrual women. Lancet 1994; 343: 269–70
   PubMed Web of Science ®Google Scholar
• Selby J. V., Austin M. A., Newman B., Zhang D., Quesenberry C. P., Mayer E. J., Krauss R. M. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993; 88: 381–7
   PubMed Web of Science ®Google Scholar
• Murai A., Miyahara T., Fujimoto N., Matzuda M., Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59: 199–204
   PubMed Web of Science ®Google Scholar
• Heinrich J., Sandkamp M., Kokott R., Schulte H., Assman G. Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin. Chem. 1991; 37: 1950–4
   PubMed Web of Science ®Google Scholar
• Solymoss B., Marcil M., Wesolwoska E., Gilfix B., Lesperance J., Campeau L. Relation of coronary artery disease in women aged less than 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high density cholesterol ratio. Am. J. Cardiol. 1993; 72: 1215–9
   PubMed Web of Science ®Google Scholar
• Montgomery J., Crook D., Godsland I., Wynn V., Studd J. Plasma lipid risk factors in oophorectomised women. Br. J. Obstet. Gynaecol. 1989; 96: 1236–8
   PubMedGoogle Scholar
• Matthews K., Meilahn E., Kuller L., Kelsey S., Caggiula A., Wing R. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 1989; 321: 641–6
   PubMed Web of Science ®Google Scholar
• Stevenson J. C., Crook D., Godsland I. F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83–90
   PubMed Web of Science ®Google Scholar
• Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V., Sacks F. M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 1991; 352: 1196–204
   Google Scholar
• Crook D., Cust M., Gangar K., Worthington M., Hillard T., Stevenson J., Whitehead M., Wynn V. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am. J. Obstet. Gynecol. 1992; 166: 90–5
   Google Scholar
• Tollin C., Ericsson M., Johnson O., Back-man C. Clearance of triglycerides from the circulation and its relationship to serum lipoproteins: influence of age and sex. Scan. J. Clin. Lab. Invest. 1985; 45: 679–84
   PubMed Web of Science ®Google Scholar
• Westerveld H. T., Kock L. A. W., van Rijn J. M., Erkelens D. W., de Bruin T. S. A. 17b˜-estradiol improves postprandial lipid metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 1995; 80: 249–53
   Google Scholar
• Jensen J., Nilas L., Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990; 12: 321–31
   PubMed Web of Science ®Google Scholar
• Stevenson J., Crook D., Godsland O. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83–90
   PubMed Web of Science ®Google Scholar
• Crook D., Cust M. P., Gangar K. F., Worthington M., Hillard T. C., Stevenson J. C., Whitehead M. I., Wynn V. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am. J. Obstet. Gynecol. 1992; 166: 950–5
   PubMed Web of Science ®Google Scholar
• Srivastava R. A. K., Baumann D., Schon-feld G. in vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional levels in rat and mouse. Eur. J. Biochem. 1993; 216: 527–38
   Google Scholar
• Kushwaha R. S., Born K. M. Effect of oestrogen and progesterone on the hepatic cholesterol 7 alpha-hydroxylase activity in ovari-ectomisedbaboons. Biochim. Biophys. Acta. 1991; 1084: 300–2
   Google Scholar
• Austin M. A., Breslow J. L., Hennekens C. H., Buring J. E., Willett W. C., Krauss R. M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc 1988; 260: 1917–21
   PubMed Web of Science ®Google Scholar
• Campos H., Sacks F. M., Walsh B. W., Schiff I., O'Hanesian M. A., Krauss R. M. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 1993; 42: 1153–8
   Google Scholar
• Tikkanen M., Nikkila E., Kuusi T., Sipinen S. High density lipoprotein-2 and hepatic lipase: Reciprocal changes produced by estrogen and norgestrel. J. Clin. Endocrinol. Metab. 1982; 54: 1113–7
   PubMed Web of Science ®Google Scholar
• Schaefer E., Foster D., Zech L., Lindgren F., Brewer H., Jr, Levy R. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J. Clin. Endocrinol. Metab. 1983; 57: 262–67
   PubMed Web of Science ®Google Scholar
• Meilahan E. N., Kuller L. H., Matthews K. A., Stein E. A. Lp(a) concentrations among pre- and postmenopausal women over time: the Healthy Woman Study. Circulation 1991; 84(Suppl II)546, ), (abstr.)
   Google Scholar
• Mendoza S., Velazquez E., Osona A., Hamer T., Glueck C. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein (a). J. Lab. Clin. Med. 1994; 123: 837–41
   PubMed Web of Science ®Google Scholar
• Kim C. J., Jang H. C., Cho D. H., Min Y. K. Effects of hormone replacement therapy on lipoprotein (a) and lipids in postmenopausal women. Arteriosc. Thromb. 1994; 14: 275–81
   PubMed Web of Science ®Google Scholar
• Sacks F. M., McPherson R., Walsh B. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch. Intern. Med. 1994; 154: 1106–10
   PubMedGoogle Scholar
• van der Mooren M. J., Demacker P. N., Thomas C. M., Rolland R. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study. Eur. J. Obstet. Gynecol. Reprod. Biol 1992; 47: 153–60
   PubMed Web of Science ®Google Scholar
• Tonstad S., Ose L., Gorbitz C., Djoseland O., Bard J., Fruchart J. Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J. Int. Med. 1995; 238: 39–47
   Web of Science ®Google Scholar
• Garcia M., McNamara P., Gordon T., Kan-nell W. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1973; 23: 103–11
   Google Scholar
• Barrett-Connor E. L., Cohn B. A., Wingard D. L., Edelstein S. L. Why is diabetes mellitus a stronger risk factor for fatal ischaemic heart disease in women than in men? The Rancho Bernardo Study. J. Am. Med. Assoc 1991; 265: 627–31
   PubMed Web of Science ®Google Scholar
• Moller D., Flier J. Insulin resistance - mechanisms, syndromes, and implications. N. Engl. J. Med. 1991; 325: 938–48
   PubMed Web of Science ®Google Scholar
• Pyörälä K., Savolainen E., Kaukola S., Kaapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2 year follow-up of the Helsinki Policemen Study population. Acta. Med. Scand. 1985; 701(Suppl)38–52, )
   Google Scholar
• Eschwège E., Richard J., Thibult N., Ducimetiere P., Warnet J., Claude J., Rosselin G. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm. Metab. Res. 1985; 15(Suppl)41–6, )
   Google Scholar
• Stout R. Insulin and atheroma: 20-year perspective. Diabetes Care 1990; 13: 631–54
   PubMed Web of Science ®Google Scholar
• Hollenbeck C., Reaven G. M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 1987; 64: 1169–73
   Google Scholar
• Walton C., Godsland I., Proudler A., Wynn V., Stevenson J. The effects of the menopause on insulin sensitivity, secretion and elimination in nonobese, healthy women. Eur. J. Clin. Invest. 1993; 23: 466–73
   PubMed Web of Science ®Google Scholar
• Proudler A., Felton C., Stevenson J. Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin. Sci. 1992; 83: 489–94
   PubMed Web of Science ®Google Scholar
• Godsland I. F., Walton C. M., Stevenson J. C. Impact of menopause on metabolism. Metabolism in the Female Life Cycle , M. P. Diamond, F. Naftolin. Ares Serono Symposia, Rome 1993; 171–89
   Google Scholar
• Godsland I. F., Crook D., Stevenson J. C., Collins P., Rosano G. M., Lees B., Sidhu M., Poole-Wilson P. A. Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. Br. Heart J. 1995; 74: 47–52
   PubMedGoogle Scholar
• Cagnacci A., Soldani R., Carriero P., Paoletti A., Fioretti P., Melis G. Effects of low doses of transdermal 17b˜-estradiol on carbohydrate metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 1992; 74: 1396–400
   PubMed Web of Science ®Google Scholar
• Godsland I. F. The influence of female sex steroids on glucose metabolism and insulin action. J. Int. Med. 1996; 240(Suppl 738)1–60, )
   Google Scholar
• Lewis J. T., Foglia V. G., Rodriguez R. R. The effects of steroids on the incidence of diabetes in rats after subtotal pancreatectomy. Endocrinology 1950; 46: 111–21
   Google Scholar
• Faure A., Sutter-Dub M. T. Insulin secretion from isolated pancreatic islets in the female rat. Short and long term estradiol influence. J. Physiol. (Paris) 1979; 75: 289–95
   Google Scholar
• Gilmour K., McKerns K. Insulin and estrogen regulation of lipid synthesis in adipose tissue. Biochim. Biophys. Acta 1966; 116: 220–8
   Google Scholar
• Rushakoff R., Kalkhoff R. Effects of pregnancy and sex steroid administration on skeletal muscle metabolism in the rat. Diabetes 1981; 30: 545–50
   PubMedGoogle Scholar
• Tesone M., Chazenbalk G., Ballejos G. Estrogen receptor in rate pancreatic islets. J. Ster. Biochem. 1979; 11: 1309–14
   PubMedGoogle Scholar
• Dubé J. Y., Lesage R., Tremblay R. R. Androgen and estrogen binding in rat skeletal and perineal muscle. Can. J. Biochem. 1976; 54: 50–5
   PubMedGoogle Scholar
• Wade G. N., Gray J. M. Cytoplasmic 17b˜-[3H] estradiol binding in rat adipose tissue. Endocrinology 1978; 103: 1695–701
   PubMed Web of Science ®Google Scholar
• Lapidus I., Bengtsson C., Larsson B., Pennert K., Rybo F., Sjostrom I. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. 1984; 289: 1257–61
   PubMed Web of Science ®Google Scholar
• Stern M., Haffner S. Body fat distribution and hyperinsulinaemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986; 6: 123–30
   PubMedGoogle Scholar
• Ley C. J., Lees B., Stevenson J. C. Sex- and menopause-associated changes in body-fat distribution. Am. J. Clin. Nutr. 1992; 55: 950–4
   PubMed Web of Science ®Google Scholar
• Svendsen W., Hassager C., Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 1995; 44: 369–73
   PubMed Web of Science ®Google Scholar
• Haarbo J., Marslew U., Gotfredsen A., Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40: 1323–26
   PubMed Web of Science ®Google Scholar
• Jensen M., Martin M., Cryer P., Roust L. Effects of estrogen on free fatty acid metabolism in humans. Am. J. Physiol. 1994; 266: E914–e20
   Google Scholar
• Biology of Endothelial Cells. , E. A. Jaffe. Martinus Nijhofl, Boston 1984
   Google Scholar
• Petty R. G., Pearson J. D. Endothelium - the axis of vascular health and disease. J. Royal Coll. Phys. 1989; 23: 92–102
   PubMed Web of Science ®Google Scholar
• Palmer R. M. J., Ashton D. S., Moncada S. Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature 1988; 333: 664–6
   PubMed Web of Science ®Google Scholar
• Madri J. A., Pratt B. M., Yannariello-Brown J. Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am. J. Pathol. 1988; 132: 18–27
   PubMed Web of Science ®Google Scholar
• Campbell J. H., Campbell G. R. Endothelial cell influences on vascular smooth muscle phenotype. Ann. Rev. Physiol. 1986; 48: 295–306
   PubMed Web of Science ®Google Scholar
• Zeiher A., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolaemia, and hypertension. J. Clin. Invest. 1993; 92: 652–62
   PubMed Web of Science ®Google Scholar
• Gangar K. F., Reid B. A., Crook D., Hillard T. C., Whitehead M. I. oestrogens and atherosclerotic vascular disease - local vascular factors. Baillière's Clinical Endocrinology and Metabolism: The Menopause , H. J. Burger. Bailliere Tindall, London 1993; 47–59
   Google Scholar
• Gangar K. F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839–42
   PubMed Web of Science ®Google Scholar
• Jiang C., Sarrel P., Lindsay D., Poole-Wilson P., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17b˜-oestradiol. in vitro. Br. J. Pharmacol. 1991; 104: 1033–7
   PubMed Web of Science ®Google Scholar
• Hayashi T., Yamada K., Esaki T., Kuzuya M., Satake S., Ishikawa T., Hidika H., Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biophys. Res. Commun. 1995; 214: 847–55
   PubMed Web of Science ®Google Scholar
• Hishikawa K., Nakaki T., Marumo T., Suzuki H., Kato R., Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 1995; 360: 291–3
   PubMed Web of Science ®Google Scholar
• Herrington D., Braden G., Williams K., Morgan T. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 1994; 73: 951–2
   PubMed Web of Science ®Google Scholar
• Chang W. C., Nakao J., Orimo H., Murota S. E. Stimulation of prostaglandin cyclo-oxygenase and prostaglandin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochem. Biophys. Acta 1980; 620: 472–82
   Google Scholar
• Beldekas J. C., Smith B., Gerstenfeld L. C., Soneshein G. E., Franzblau C. Effects of 17b˜-estradiol on biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 1981; 20: 2162–7
   PubMed Web of Science ®Google Scholar
• Haarbo J., Leth-Espensen P., Stender S., Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomised cholesterol-fed rabbits. J. Clin. Invest. 1991; 87: 1274–9
   PubMed Web of Science ®Google Scholar
• Tranquilli A., Mazzanti L., Cugini A., Cester N., Garzetti G., Romanini C. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecol. Endocrinol. 1995; 9: 137–41
   PubMed Web of Science ®Google Scholar
• Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 1987; 210: 37–9
   PubMed Web of Science ®Google Scholar
• Kotake H., Sawada Y., Hoshio A., Shirota K., Tomokuni A., Doi T., Hisatome I., Mashiba H. Relation between serum uric acid and angiographically defined coronary artery disease in postmenopausal women. J. Med. 1992; 23: 409–15
   Google Scholar
• Wilding P., Rollason J., Robinson D. Patterns of change for various biochemical constituents detected in well population screening. Clin. Chim. Acta 1972; 41: 375
   PubMed Web of Science ®Google Scholar
• Staessen J., Bulpitt C. J., Fagard R., Lijnen P., Amery A. The influence of menopause on blood pressure. J. Hum. Hypertens. 1989; 3: 427–33
   PubMed Web of Science ®Google Scholar
• Eferakaya A., Imasuen J. Relationship of menopause to serum cholesterol and arterial blood pressure in some Nigerian women. Pub. Health 1986; 100: 28–32
   Google Scholar
• Luotola H. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution. Ann. Clin. Res. 1983; 15: 119–2
   Google Scholar
• Lind T., Cameron E., Hunter W. A prospective controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br. J. Obstet. Gynaecol. 1979; 86(Suppl3)1–29, )
   Google Scholar
• Wren B., Routledge A. The effect of type and dose of oestrogen on the blood pressure ofpost-menopausal women. Maturitas 1983; 5: 135–42
   PubMed Web of Science ®Google Scholar
• Ylikorkala O., Orpana A., Puolakka J., Pyorala T., Viinikka L. Postmenopausal hormonal replacement decreases plasma levels of en-dothelin-1. J. Clin. Endocrinol. Metab. 1995; 80: 3384–7
   PubMed Web of Science ®Google Scholar
• Stone M., Thorp J. Plasma fibrinogen - a major coronary risk factor. J. Roy. Coll. Gen. Prac 1985; 35: 565–9
   PubMedGoogle Scholar
• Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North R. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533–37
   Google Scholar
• Wilhelmsen L., Svärdsudd K., Korsan-Bengsten K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 1984; 311: 501–5
   PubMed Web of Science ®Google Scholar
• Aznar J., Estelles A., Tormo G., Sapena P., Tormo V., Blanch S., Espana F. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br. Heart J. 1988; 59: 535–41
   PubMedGoogle Scholar
• Scarabin P. Y., Bonithon-Kopp C., Malmejac B. L., Guize L. Factor VII activation and menopausal status. Thromb. Res. 1990; 57: 227–34
   PubMedGoogle Scholar
• Bonithon-Dopp C., Scarabin P. Y., Darne B., Melmejac A., Guize L. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int. J. Epidemiol. 1990; 19: 42–8
   Google Scholar
• Balleisen L., Bailey J., Epping P. H., Schulte H., van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation of age, gender, body weight, smoking, alcohol, pill use and menopause. Thromb. Haemost. 1985; 54: 475–79
   PubMed Web of Science ®Google Scholar
• Meade T. W., Dyer S., Howarth D. J., Imeson J. D., Stirling Y. Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br. J. Haematol. 1990; 74: 77–81
   PubMed Web of Science ®Google Scholar
• Winkler U. H. Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings. Fibrinolysis 1992; 6(Suppl 3)5–10, )
   Google Scholar
• Meade T. W., Chakrabarti R., Haines A. P., North W. R. S., Stirling Y., Thompson S. G. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; i: 1050–54
   Google Scholar
• Notelovitz M., Kitchens C., Rappaport V., Coone L., Dougherty M. Menopausal status associated with increased inhibition ofblood coagulation. Am. J. Obstet. Gynecol. 1981; 141: 149–52
   Google Scholar
• Scarabin P. Y., Plu-Bureau G., Bara L., Bonithon-Kopp C., Guize L., Samama M. M. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb. Haemost. 1993; 70: 584–7
   PubMed Web of Science ®Google Scholar
• Gilabert J., Estellés A., Cano A., España F., Barrachina R., Grancha S., Aznar J., Torta-jada M. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status. Am. J. Obstet. Gynecol. 1995; 173: 1849–54
   PubMed Web of Science ®Google Scholar
• Lindstedt G., Lundberg P., Lapidus L., Lundgren H., Bengtsson C., Bjorntorp P. Low sex-hormone binding globulin concentration as independent risk factor for development of NIDDM. Diabetes 1991; 40: 123–8
   PubMed Web of Science ®Google Scholar
• Nestler J. Editorial: sex hormone binding globulin: a marker for hyperinsulinaemia and/or insulin resistance?. J. Clin. Endocrinol. Metab. 1993; 76: 273–4
   PubMed Web of Science ®Google Scholar
• Haffner S., Valdez R. Endogenous sex hormones: impact on lipids, lipoproteins and insulin. Am. J. Med. 1995; 98(Suppl 1A), ), 40S-7S
   Google Scholar
• Pasquali R., Casimirri F., Labate A., Tortelli O., Pascal G., Anconetani B., Gatto M., Flamia R., Capelli M., Barbara L. Body weight, fat distribution and the menopausal status in women. Int. J. Obes. 1994; 18: 614–21
   PubMed Web of Science ®Google Scholar
• Preziosi P., Barrett-Connor E., Papoz L., Roger M., Saint-Paul M., Nahoul K., Simon D. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom Study. J. Clin. Endocrinol. Metab. 1993; 76: 283–7
   PubMed Web of Science ®Google Scholar
• Haffner S., Dunn J., Katz M. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992; 41: 278–84
   PubMed Web of Science ®Google Scholar
• Rannevik G., Jappsson S., Johnell O., Bjerre B., Laurell-Bonulf Y., Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995; 21: 103–13
   PubMed Web of Science ®Google Scholar
• Gershagen S., Doeberl A., Jeppsson S., Rannevik G. Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study. Fertil. Steril. 1989; 51: 616–21
   PubMed Web of Science ®Google Scholar
• Haffner S., Katz M., Stern M., Dunn J. The relationship between sex hormones to hyperinsulinaemia and hyperglycaemia. Metabolism 1988; 37: 683–8
   PubMed Web of Science ®Google Scholar
• Wild R., Applebaum-Bowden D., Demers L. Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin. Chem. 1990; 36: 283–9
   PubMed Web of Science ®Google Scholar
• Haffner S., Katz M., Dunn J. The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulin. Endocr. Res. 1990; 16: 361–76
   PubMed Web of Science ®Google Scholar
• Birkeland K., Hanssen K., Torjesen P., Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J. Clin. Endocrinol. Metab. 1993; 76: 275–8
   PubMed Web of Science ®Google Scholar
• van der Mooren M., Demacker P., Thomas C., Borm G., Rolland R. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone. Eur. J. Obstet. Gynecol. Reprod. Biol 1993; 52: 117–23
   PubMed Web of Science ®Google Scholar
• Frayn K. Insulin resistance and lipid metabolism. Curr. Opin. Lipidol. 1993; 4: 197–204
   Google Scholar
• Baron A. D. Hemodynamic actions of insulin. Am. J. Physiol. 1994; 267: E187–E202
   PubMed Web of Science ®Google Scholar
• Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132–43
   PubMed Web of Science ®Google Scholar
• Fuh M. M.-T., Jeng C. Y., Young M. M.-S., Sheu W. H.-H., Chen Y. D. I., Reaven G. M. Insulin resistance, glucose intolerance and hyperinsulinaemia in patients with microvascular angina. Metabolism 1993; 42: 1090–92
   Google Scholar
• Godsland I. F., Crook D., Stevenson J. C., Collins P., Rosano G. M., Lees B., Sidhu M., Poole-Wilson P. A. Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. Br. Heart J. 1995; 74: 47–52
   PubMedGoogle Scholar
• Ader M., Bergman R. N. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am. J. Physiol. 1994; 266: E17–E25
   Google Scholar
• Eckel R. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 1989; 320: 1060–8
   PubMed Web of Science ®Google Scholar
• Vague P., Juhan-Vague I., Aillaud M., Badier C., Viard R., Alessi M., Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250–53
   PubMed Web of Science ®Google Scholar
• Alessi M. C., Juhan-Vague I., Kooistra T., Declerck P. J., Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by hepatocellular cell line HepG2. Thromb. Haemost. 1988; 60: 491–94
   PubMed Web of Science ®Google Scholar
• Coagulation and fibrinolytic factors, insulin resistance and the metabolic syndrome of coronary heart disease risk. Meeting of the European Society of Cardiology. Birmingham 1996
   Google Scholar
• Reaven G. M. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Ann. Rev. Med. 1993; 44: 121–31
   PubMed Web of Science ®Google Scholar
• Eliasson B., Attwall S., Taskinen M., Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arteriosc. Thromb. 1994; 14: 1946–50
   PubMed Web of Science ®Google Scholar
• Jensen J., Christiansen C., Rodbro P. Cigarette smoking, serum estrogens and bone loss during hormone replacement therapy after the menopause. N. Engl. J. Med. 1985; 313: 973–5
   PubMed Web of Science ®Google Scholar
• Byrjalsen I., Haarbo J., Christiansen C. Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestin therapy. Obstet. Gynecol. 1993; 81: 1016–21
   PubMed Web of Science ®Google Scholar
• Jensen J., Christiansen C. Effects of smoking on lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am. J. Obstet. Gynecol 1988; 159: 820–5
   PubMed Web of Science ®Google Scholar
• Facchini F., Chen Y. D., Reaven G. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994; 17: 115–9
   PubMed Web of Science ®Google Scholar
• Mayer E., Newman B., Quesenberry C., Friedman G., Selby J. Alcohol consumption and insulin concentrations: role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 1993; 88: 2190–7
   PubMed Web of Science ®Google Scholar
• Reichman M., Judd J., Longcope C., Schatzkin A., Clevidence A., Nair P., Campbell W., Taylor P. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J. Natl. Cancer Inst. 1993; 85: 722–7
   PubMed Web of Science ®Google Scholar
• Gavaler J., Love K. Detection of the relationship between moderate alcoholic beverage consumption and serum levels of estradiol in normal postmenopausal women: effects of alcohol consumption, quantitation methods and sample size adequacy. J. Stud. Alcohol 1992; 53: 389–94
   Web of Science ®Google Scholar
• Svendsen L., Hassager C., Christiansen C. Relationships and interdependence of body fat composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women. Int. J. Obes. 1993; 17: 459–63
   PubMed Web of Science ®Google Scholar